The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit
Open accessAbstract
Uptake of low-density lipoprotein (LDL) particles by macrophages represents a key step in the development of atherosclerotic plaques, leading to the foam cell formation. Chemical modification of LDL is however necessary to induce this process. Proatherogenic LDL modifications include aggregation, enzymatic digestion and oxidation. LDL oxidation by one-electron (free radicals) and two-electron oxidants dramatically increases LDL affinity to macrophage scavenger receptors, leading to rapid LDL uptake and fatty streak formation. Circulating high-density lipoprotein (HDL) particles, primarily small, dense, protein-rich HDL3, provide potent protection of LDL from oxidative damage by free radicals, resulting in the inhibition of the generation of pro-inflammatory oxidized lipids. HDL-mediated inactivation of lipid hydroperoxides involves their initial transfer from LDL to HDL and subsequent reduction to inactive hydroxides by redox-active Met residues of apolipoprotein A-I. Several HDL-associated enzymes are present at elevated concentrations in HDL3 relative to large, light HDL2 and can be involved in the inactivation of short-chain oxidized phospholipids. Therefore, HDL represents a multimolecular complex capable of acquiring and inactivating proatherogenic lipids. Antioxidative function of HDL can be impaired in several metabolic and inflammatory diseases. Structural and compositional anomalies in the HDL proteome and lipidome underlie such functional deficiency. Concomitant normalization of the metabolism, circulating levels, composition and biological activities of HDL particles, primarily those of small, dense HDL3, can constitute future therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,880
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Antioxidant defenses and lipid peroxidation in human blood plasma.
Frei, B., Stocker, R., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9748 · Cited by 1,252
Plasma lipoproteins: apolipoprotein structure and function.
Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155
Serum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C. M., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,106
Vitamins C and E: Beneficial effects from a mechanistic perspective
Traber, M. G., & Stevens, J. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.017 · Cited by 1,076
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Wayner, D. D. M., Burton, G. W., Ingold, K. U., Barclay, L. R. C., & Locke, S. J. (1987) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(87)90155-3 · Cited by 872
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 715
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.98.15.1487 · Cited by 673
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Self-citationHarel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646
Bhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 533
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 511
Self-citationBowry, V. W., Stanley, K. K., & Stocker, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10316 · Cited by 479
Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 477
Self-citationZalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471
Self-citationOxidized Low-Density Lipoprotein and Atherosclerosis
Steinberg, D., & Witztum, J. L. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179697 · Cited by 460
Parthasarathy, S., Khoo, J. C., Miller, E., Barnett, J., Witztum, J. L., & Steinberg, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3894 · Cited by 459
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Structure−Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase
Khersonsky, O., & Tawfik, D. S. (2005) · Biochemistry · doi:10.1021/bi047440d · Cited by 456
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
Self-citationThe Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
McMahon, M., Grossman, J., FitzGerald, J., Dahlin‐Lee, E., Wallace, D. J., Thong, B. Y., Badsha, H., Kalunian, K., Charles, C., Navab, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21976 · Cited by 431
Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study
Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M., & Mackness, M. (2003) · Circulation · doi:10.1161/01.cir.0000070954.00271.13 · Cited by 421
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Self-citationThe LDL modification hypothesis of atherogenesis: an update
Steinberg, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800087-jlr200 · Cited by 375
Navab, M., Hama, S. Y., Cooke, C. J., Anantharamaiah, G. M., Chaddha, M., Jin, L., Subbanagounder, G., Faull, K. F., Reddy, S. T., Miller, N. E., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33461-1 · Cited by 362
Mackness, B., Durrington, P. N., & Mackness, M. I. (1998) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(98)00028-7 · Cited by 350
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
Kontush, A., & Chapman, M. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0500 · Cited by 342
Self-citationApolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes
Pérez-Morga, D., Vanhollebeke, B., Paturiaux-Hanocq, F., Nolan, D. P., Lins, L., Homblé, F., Vanhamme, L., Tebabi, P., Pays, A., Poelvoorde, P., et al. (2005) · Science · doi:10.1126/science.1114566 · Cited by 339
A Novel Human Apolipoprotein (apoM)
Xu, N., & Dahlbäck, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31286 · Cited by 335
Human kidney proximal tubules are the main source of plasma glutathione peroxidase
Avissar, N., Ornt, D. B., Yagil, Y., Horowitz, S., Watkins, R. H., Kerl, E. A., Takahashi, K., Palmer, I. S., & Cohen, H. J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.2.c367 · Cited by 324
Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320
Oxidation of High Density Lipoproteins
Garner, B., Waldeck, A. R., Witting, P. K., Rye, K.-A., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6088 · Cited by 319
Camont, L., Lhomme, M., Rached, F., Le Goff, W., Nègre-Salvayre, A., Salvayre, R., Calzada, C., Lagarde, M., Chapman, M. J., & Kontush, A. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301468 · Cited by 319
Self-citationThe Amphipathic α Helix: A Multifunctional Structural Motif in Plasma Apolipoproteins
Segrest, J. P., Garber, D. W., Brouillette, C. G., Harvey, S. C., & Anantharamaiah, G. M. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60643-9 · Cited by 311
Mackness, M. I., Abbott, C., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 305
Cardioprotective functions of HDLs
Rye, K.-A., & Barter, P. J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r039297 · Cited by 299
Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298
Self-citationAntiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Kontush, A., & Chapman, M. J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833bcdc1 · Cited by 293
Self-citationYoshida, H., & Kisugi, R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.038 · Cited by 288
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67478 · Cited by 269
Maddipati, K. R., & Marnett, L. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45392-6 · Cited by 232
Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., & Motulsky, A. G. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90424-7 · Cited by 230
Kontush, A., Therond, P., Zerrad, A., Couturier, M., Négre-Salvayre, A., de Souza, J. A., Chantepie, S., & Chapman, M. J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145672 · Cited by 229
Self-citationGaidukov, L., & Tawfik, D. S. (2005) · Biochemistry · doi:10.1021/bi050862i · Cited by 222
Nob�court, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M. J., & Kontush, A. (2005) · Diabetologia · doi:10.1007/s00125-004-1655-5 · Cited by 220
Self-citationWan, G., Zhaorigetu, S., Liu, Z., Kaini, R., Jiang, Z., & Hu, C.-A. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800214200 · Cited by 218
Tselepis, A. D., Dentan, C., Karabina, S.-A. P., Chapman, M. J., & Ninio, E. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1764 · Cited by 198
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
Moradi, H., Pahl, M. V., Elahimehr, R., & Vaziri, N. D. (2009) · Translational Research · doi:10.1016/j.trsl.2008.11.007 · Cited by 194
Quarck, R., De Geest, B., Stengel, D., Mertens, A., Lox, M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., et al. (2001) · Circulation · doi:10.1161/01.cir.103.20.2495 · Cited by 193
Goulinet, S., & Chapman, M. J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.786 · Cited by 191
Charles‐Schoeman, C., Fleischmann, R., Davignon, J., Schwartz, H., Turner, S. M., Beysen, C., Milad, M., Hellerstein, M. K., Luo, Z., Kaplan, I. V., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38974 · Cited by 188
Tang, W. H. W., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F. R., Erdmann, J., Kathiresan, S., The CARDIoGRAM Consortium, Roberts, R., McPherson, R., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.253930 · Cited by 174
Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 173
Mackness, M., Arrol, S., Mackness, B., & Durrington, P. N. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61755-2 · Cited by 173
Mallat, Z., Lambeau, G., & Tedgui, A. (2010) · Circulation · doi:10.1161/circulationaha.110.936393 · Cited by 170
The emerging roles of PAF acetylhydrolase
McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800024-jlr200 · Cited by 165
The Role of High-Density Lipoproteins in Oxidation and Inflammation
Van Lenten, B. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00095-0 · Cited by 165
Gowri, M. S., Van der Westhuyzen, D. R., Bridges, S. R., & Anderson, J. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2226 · Cited by 164
Miller, Y. I., Choi, S.-H., Fang, L., & Tsimikas, S. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_8 · Cited by 161
Zerrad-Saadi, A., Therond, P., Chantepie, S., Couturier, M., Rye, K.-A., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194555 · Cited by 160
Self-citationOstos, M. A., Conconi, M., Vergnes, L., Baroukh, N., Ribalta, J., Girona, J., Caillaud, J.-M., Ochoa, A., & Zakin, M. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1023 · Cited by 158
Phospholipase A2 enzymes and the risk of atherosclerosis
Rosenson, R. S., & Hurt‐Camejo, E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs148 · Cited by 147
Oxidative Modification of LDL: Its Pathological Role in Atherosclerosis
Itabe, H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8095-9 · Cited by 145
Ahmed, Z., Ravandi, A., Maguire, G. F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010459200 · Cited by 145
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.001 · Cited by 144
Self-citationCamejo, G., Fager, G., Rosengren, B. E., Hurt‐Camejo, E., & Bondjers, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85218-3 · Cited by 143
Hydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540001 · Cited by 138
Nyyssönen, K., Porkkala-Sarataho, E., Kaikkonen, J., & Salonen, J. T. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06064-9 · Cited by 134
Fuhrman, B., Koren, L., Volkova, N., Keidar, S., Hayek, T., & Aviram, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00063-1 · Cited by 133
The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases
Park, S., Mathis, K. W., & Lee, I. K. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9275-3 · Cited by 132
Patel, P. J., Khera, A. V., Jafri, K., Wilensky, R. L., & Rader, D. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.030 · Cited by 131
Souza, J. A., Vindis, C., Nègre‐Salvayre, A., Rye, K., Couturier, M., Thérond, P., Chantepie, S., Salvayre, R., Chapman, M. J., & Kontush, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00713.x · Cited by 128
Self-citationPopa, C. D., van Tits, L. J. H., Barrera, P., Lemmers, H., van den Hoogen, F. H. J., van Riel, P. L. C. M., Radstake, T. R. D. J., Netea, M. G., Roest, M., & Stalenhoef, A. F. H. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092171 · Cited by 128
Ribas, V., Sánchez‐Quesada, J. L., Antón, R. I., Camacho, M., Julve, J., Escolá‐Gil, J. C., Vila, L., Ordóñez‐Llanos, J., & Blanco‐Vaca, F. (2004) · Circulation Research · doi:10.1161/01.res.0000146031.94850.5f · Cited by 127
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
Elsøe, S., Ahnström, J., Christoffersen, C., Hoofnagle, A. N., Plomgaard, P., Heinecke, J. W., Binder, C. J., Björkbacka, H., Dahlbäck, B., & Nielsen, L. B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.031 · Cited by 121
Tabet, F., Remaley, A. T., Ségaliny, A. I., Millet, J. R., Yan, L., Nakhla, S., Barter, P. J., Rye, K., & Lambert, G. C. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200196 · Cited by 121
Tsimihodimos, V., Kakafika, A. I., Tambaki, A. P., Bairaktari, E. T., Chapman, M. J., Elisaf, M., & Tselepis, A. D. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200452-jlr200 · Cited by 118
Novel Function of Lecithin-Cholesterol Acyltransferase
Goyal, J., Wang, K., Liu, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16231 · Cited by 114
Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.
Fruebis, J., Parthasarathy, S., & Steinberg, D. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10588 · Cited by 113
HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Proudfoot, J. M., Barden, A. E., Loke, W. M., Croft, K. D., Puddey, I. B., & Mori, T. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800607-jlr200 · Cited by 112
Curtiss, L. K., Bonnet, D. J., & Rye, K. (2000) · Biochemistry · doi:10.1021/bi992902m · Cited by 110
Sparks, D. L., Davidson, W. S., Lund‐Katz, S., & Phillips, M. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26910 · Cited by 110
Christison, J. K., Rye, K., & Stocker, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41119-8 · Cited by 107
Didichenko, S. A., Navdaev, A. V., Cukier, A. M. O., Gille, A., Schuetz, P., Spycher, M. O., Thérond, P., Chapman, M. J., Kontush, A., & Wright, S. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.308685 · Cited by 106
Self-citationMolecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions
Yamashita, S., Tsubakio‐Yamamoto, K., Ohama, T., Nakagawa-Toyama, Y., & Nishida, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5405 · Cited by 106
Structure and Function of HDL Mimetics
Navab, M., Shechter, I., Anantharamaiah, G. M., Reddy, S. T., Lenten, B. J. V., & Fogelman, A. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.187518 · Cited by 104
Smith, K., Lawn, R. M., & Wilcox, J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42739-7 · Cited by 103
Plasma metabolism of apolipoprotein A-IV in humans.
Ghiselli, G. C., Krishnan, S., Beigel, Y., & Gotto, A. M. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38785-x · Cited by 102
Zhang, N., Ahsan, M. H., Purchio, A. F., & West, D. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8125 · Cited by 96
Hydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/bj3540001 · Cited by 96
Zhang, J., Zhang, Y., Liu, H., Bai, H., Wang, Y., Jiang, C., & Fan, P. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.02.024 · Cited by 95
Casella–Filho, A., Chagas, A. C. P., Maranhão, R. C., Trombetta, I. C., Cesena, F. Y., Silva, V. M., Tanus-Santos, J. E., Negrão, C. E., & da Luz, P. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.12.014 · Cited by 94
Girotti, A. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.004 · Cited by 92
A novel approach to oral apoA-I mimetic therapy
Chattopadhyay, A., Navab, M., Hough, G., Gao, F., Meriwether, D., Grijalva, V. R., Springstead, J. R., Palgnachari, M. N., Namiri‐Kalantari, R., Su, F., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m033555 · Cited by 92
Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function
Bashtovyy, D., Jones, M. K., Anantharamaiah, G. M., & Segrest, J. P. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r012658 · Cited by 92
Zhang, X., Dong, X., Zheng, L., et al. (2003) · Acta Histochemica · doi:10.1078/0065-1281-00687 · Cited by 90
Harangi, M., Seres, I., Varga, Z., Emri, G., Szilv�ssy, Z., Paragh, G., & Remenyik, �. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0820-6 · Cited by 81
Ng, D. S., Chu, T., Esposito, B., Hui, P., Connelly, P. W., & Gross, P. L. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2007.10.001 · Cited by 80
Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides
D’Souza, W., Stonik, J. A., Murphy, A. J., Demosky, S. J., Sethi, A. A., Moore, X. L., Chin-Dusting, J. P. F., Remaley, A. T., & Sviridov, D. (2010) · Circulation Research · doi:10.1161/circresaha.110.216507 · Cited by 80
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118276.87061.00 · Cited by 79
Self-citationBhatia, S., Knoch, B., Wong, J., Kim, W. S., Else, P. L., Oakley, A. J., & Garner, B. (2011) · Biochemical Journal · doi:10.1042/bj20111166 · Cited by 78
Simionescu, M., & Simionescu, N. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.14.8224609 · Cited by 77
Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins
Panzenboeck, U., & Stocker, R. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.003 · Cited by 76
Teiber, J. F., Draganov, D. I., & Du, B. N. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400213-jlr200 · Cited by 76
Wool, G. D., Reardon, C. A., & Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700552-jlr200 · Cited by 73
Yoshikawa, M., SAKUMA, N., Hibino, T., Sato, T., & Fujinami, T. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00031-3 · Cited by 72
Morena-Carrere, M., Cristol, J., DANTOINE, T. F., Carbonneau, M., Descomps, B., & Canaud, B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.3.389 · Cited by 72
Kaplon, R. E., Gano, L. B., & Seals, D. R. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00969.2013 · Cited by 72
Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph.
Ohta, T., Fidge, N., & Nestel, P. J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112081 · Cited by 71
Bergt, C., Marsche, G., Panzenboeck, U., Heinecke, J. W., Malle, E., & Sattler, W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02253.x · Cited by 70
Steel, D. M., Sellar, G. C., Uhlar, C., Simon, S., deBeer, F. C., & Whitehead, A. S. (1993) · Genomics · doi:10.1006/geno.1993.1209 · Cited by 70
Chen, N., Liu, Y., Greiner, C. D., & Holtzman, J. L. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.107692 · Cited by 70
Gaál, K., Tarr, T., Lőrincz, H., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0229-0 · Cited by 70
Navab, M., Hough, G., Buga, G. M., Su, F., Wagner, A. C., Meriwether, D., Chattopadhyay, A., Gao, F., Grijalva, V. R., Danciger, J. S., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m042051 · Cited by 69
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678 · Cited by 68
Self-citationParaoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite
Connelly, P. W., Draganov, D. I., & Maguire, G. F. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.010 · Cited by 68
Miyamoto–Sasaki, M., Yasuda, T., Monguchi, T., Nakajima, H., Mori, K., Toh, R., Ishida, T., & Hirata, K. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17210 · Cited by 67
Miyazaki, A., Sakai, M., Suginohara, Y., Hakamata, H., Sakamoto, Y., Morikawa, W., & Horiuchi, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37683-4 · Cited by 66
Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women
Zago, V., Sanguinetti, S. M., Brites, F. D., Berg, G. A., Verona, J., Basilio, F., Wikinski, R. L. W., & Schreier, L. E. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.011 · Cited by 65
Self-citationDobiášová, M., & Frohlich, J. J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00106-0 · Cited by 62
Rached, F. H., Lhomme, M., Camont, L., Gomes, F. L. T., Dauteuille, C., Robillard, P., Santos, R. D., Lesnik, P., Junior, C. V. S., Chapman, M. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.05.007 · Cited by 61
Self-citationHadfield, K. A., Pattison, D. I., Brown, B. E., Hou, L., Rye, K., Davies, M. J., & Hawkins, C. L. (2012) · Biochemical Journal · doi:10.1042/bj20121210 · Cited by 61
She, Z., Zheng, W., Wei, Y.-S., Chen, H., Wang, A., Li, H.-L., Liu, G., Zhang, R., Liu, J., Stallcup, W. B., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.192229 · Cited by 60
Milanlıoğlu, A., Aslan, M., Özkol, H., Çilingir, V., Aydın, M. N., & Karadaş, S. (2015) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0742-6 · Cited by 60
Mirdamadi, H. Z., Sztanek, F., Derdák, Z., Seres, I., Harangi, M., & Paragh, G. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03213.x · Cited by 60
Filou, S., Lhomme, M., Karavia, E. A., Kalogeropoulou, C. P., Theodoropoulos, V., Zvintzou, E., Sakellaropoulos, G. C., Πετροπούλου, Π.-Ι., Constantinou, C., Kontush, A., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00389 · Cited by 60
Self-citationReconsideration of hydrophobic lipid distributions in lipoprotein particles
Kumpula, L. S., Kumpula, J. M., Taskinen, M., Jauhiainen, M., Kaski, K. K., & Ala‐Korpela, M. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.06.003 · Cited by 58
Zhou, H., Tan, K. C. B., Shiu, S. W. M., & Wong, Y. M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm631 · Cited by 58
Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status
Nagila, A., Permpongpaiboon, T., Tantrarongroj, S., et al. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70146-x · Cited by 57
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
Boisfer, E., Stengel, D., Pastier, D., Laplaud, P. M., Dousset, N., Ninio, E., & Kalopissis, A. D. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30115-2 · Cited by 57
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Wang, M., Lang, X., Cui, S., Zou, L.-J., Cao, J., Wang, S., & Wu, X.-T. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1478 · Cited by 56
Functionality of HDL: Antioxidation and Detoxifying Effects
Karlsson, H., Kontush, A., & James, R. W. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_5 · Cited by 55
Self-citationMohamadin, A. M., Habib, F., & Elahi, T. F. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.004 · Cited by 54
ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I
Gaidukov, L., I, V. R., Yacobson, S., Rosenblat, M., Aviram, M., & Tawfik, D. S. (2009) · Biochemistry · doi:10.1021/bi9013227 · Cited by 54
Shen, Y. H., Ding, F. H., Sun, J. T., Pu, L. J., Zhang, R., Zhang, Q., Chen, Q., Shen, W. F., & Lu, L. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0221-4 · Cited by 52
Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein
Sato, M., Ohkawa, R., Yoshimoto, A., Yano, K., Ichimura, N., Nishimori, M., Okubo, S., Yatomi, Y., & Tozuka, M. (2016) · Bioscience Reports · doi:10.1042/bsr20160075 · Cited by 52
HDL capacity to inhibit LDL oxidation in well-trained triathletes
Brites, F. D., Zago, V., Verona, J., Muzzio, M. L., Wikinski, R. L. W., & Schreier, L. E. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.015 · Cited by 51
Self-citationZhang, C., Peng, W., WANG, M., Zhu, J., Zang, Y., Shi, W., Zhang, J., & Qin, J. (2010) · Gene Therapy · doi:10.1038/gt.2010.11 · Cited by 50
Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism
Albers, J. J., & Cheung, M. C. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00004 · Cited by 50
Increased methionine sulfoxide content of apoA-I in type 1 diabetes
Brock, J. W. C., Jenkins, A. J., Lyons, T. J., Klein, R. L., Yim, E., Lopes-Virella, M. F., Carter, R. E., Thorpe, S. R., & Baynes, J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800015-jlr200 · Cited by 50
Vila, A., Korytowski, W., & Girotti, A. W. (2002) · Biochemistry · doi:10.1021/bi026467z · Cited by 48
Ferretti, G., Bacchetti, T., Moroni, C., Vignini, A., & CURATOLA, G. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.10.005 · Cited by 47
Morton, R. E., Gnizak, H. M., Greene, D. J., Cho, K. H., & Paromov, V. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700258-jlr200 · Cited by 45
Rosso, L. A. G., Lhomme, M., Meroño, T., Dellepiane, A., Sorroche, P. B., Hedjazi, L., Zakiev, E., Sukhorukov, V. N., Orekhov, A. N., Gasparri, J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.10.014 · Cited by 45
Self-citationPark, K.-H., Shin, D., & Cho, K. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu076 · Cited by 44
Hamoud, S., Hayek, T., Hassan, A. F., Meilin, E., Kaplan, M., Torgovicky, R., & Cohen, R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182548c28 · Cited by 43
Zhang, X., Wang, L., & Chen, B. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0188 · Cited by 42
Arbonés-Mainar, J. M., Navarro, M. Á., Carnicer, R., Guillén, N., Surra, J. C., Acín, S., Guzmán, M., Sarría, A. J., Arnal, C., Aguilera, M. P., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.010 · Cited by 42
Bergheanu, S. C., van Tol, A., Dallinga‐Thie, G. M., Liem, A. H., Dunselman, P. H. J. M., van der Bom, J. G., & Jukema, J. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226104 · Cited by 41
HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti, S. M., Brites, F. D., Fasulo, V., Verona, J., Elbert, A. E., Wikinski, R., & Schreier, L. E. (2001) · PubMed · Cited by 40
Self-citationYlä‐Herttuala, S., Solakivi, T., Hirvonen, J., et al. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.333 · Cited by 40
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease
Paragh, G., Seres, I., Harangi, M., Balogh, Z., Illyés, L., Boda, J., Szilvássy, Z., & Kovacs, P. L. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70077-0 · Cited by 39
Kotosai, M., Shimada, S., Kanda, M., et al. (2013) · Lipids · doi:10.1007/s11745-013-3779-1 · Cited by 38
ApoA‐I mutants V156K and R173C promote anti‐inflammatory function and antioxidant activities
Cho, K. H., Park, S. H., Han, J. M., Kim, H. C., Choi, Y., & Choi, I. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01737.x · Cited by 38
Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels
Phuntuwate, W., Suthisisang, C. C., Koanantakul, B., Chaloeiphap, P., Mackness, B., & Mackness, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.001 · Cited by 37
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
Bartolo, B. A. D., Vanags, L. Z., Tan, J. T. M., Bao, S., Rye, K.-A., Barter, P. J., & Bursill, C. A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-224 · Cited by 37
Harangi, M., Mirdamadi, H. Z., Seres, I., Sztanek, F., Molnár, M., Kassai, A., Derdák, Z., Illyés, L., & Paragh, G. (2009) · Translational research · doi:10.1016/j.trsl.2009.01.007 · Cited by 34
Klimov, A. N., Kozhevnikova, K. A., Kuzmin, A. A., et al. (2001) · Biochemistry (Moscow) · doi:10.1023/a:1010203930470 · Cited by 32
A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation
McPherson, P. A. C., Young, I. S., & McEneny, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.007 · Cited by 32
Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice.
Ghezzi, P., & Sipe, J. D. (1988) · PubMed · Cited by 31
Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA
Jayaraman, S., Haupt, C., & Gursky, O. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071191 · Cited by 31
Yadav, R., Liu, Y., Kwok, S., Hama, S., France, M. W., Eatough, R., Pemberton, P., Schofield, J. D., Siahmansur, T. J., Malik, R. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001508 · Cited by 29
Meroño, T., Dauteuille, C., Tetzlaff, W., Martín, M., Botta, E., Lhomme, M., Sáez, M. S. C., Sorroche, P. B., Boero, L. E., Arbelbide, J. A., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.02.003 · Cited by 28
Self-citationHypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study
Sutherland, W. H. F., de Jong, S. A., & Walker, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg484 · Cited by 27
Batuca, J., Amaral, M., Favas, C., Paula, F., Ames, P., Papoila, A., & Alves, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13198 · Cited by 27
Hsieh, J.-Y., Chang, C., Huang, M. T.-H., Chang, C., Chen, C.-Y., Shen, M.-Y., Liao, H.-Y., Wang, G., Chen, C., Chen, C., et al. (2013) · Analytical Chemistry · doi:10.1021/ac402516u · Cited by 26
SAKUMA, N., Yoshikawa, M., Hibino, T., Ohte, N., Kamiya, T., KUNIMATSU, M., Kimura, G., & Inoue, M. (2002) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.48.278 · Cited by 23
Yeşilbursa, D., Serdar, A., Saltan, Y., Serdar, Z., Heper, Y., Güçlü, S., & Cordan, J. (2005) · PubMed · Cited by 22
Park, K.-H., Kim, J., Choi, I., Kim, J.-R., & Cho, K. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.008 · Cited by 20
Hansel, B., Bonnefont‐Rousselot, D., Orsoni, A., Bittar, R., Giral, P., Roussel, R., Marre, M., Mohammedi, K., Bruckert, É., Chapman, M. J., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.05.008 · Cited by 18
Self-citationTkáč, I., Molčányiová, A., Javorský, M., & Kozárová, M. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.12.002 · Cited by 17
ApoD mediates binding of HDL to LDL and to growing T24 carcinoma
Braesch-Andersen, S., Beckman, L., Paulie, S., & Kumagai-Braesch, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115180 · Cited by 15
Hine, D. G., Mackness, B., & Mackness, M. (2011) · IUBMB Life · doi:10.1002/iub.508 · Cited by 13
Apolipoprotein A-I-mimetic peptides with antioxidant actions
Nguyen, S. D., Jeong, T., & Sok, D. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.04.010 · Cited by 12
Lee, E., Kim, S., & Cho, K. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1644 · Cited by 2
Cited by
Metabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473
The HDL proteome watch: compilation of studies leads to new insights on HDL function
Davidson, W. S., Shah, A. S., Sexmith, H., & Gordon, S. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159072 · Cited by 107
Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.037 · Cited by 84
Zimetti, F., Adorni, M. P., Marsillach, J., Marchi, C., Trentini, A., Valacchi, G., & Cervellati, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6695796 · Cited by 49
Metadata
- Authors
- Brites, F., Martin, M., Guillas, I., & Kontush, A.
- Venue
- BBA Clinical
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 8
- Pages
- 66-77
- ISSN
- 2214-6474 (ISSN-L)
- OpenAlex
- W2746047522
- Cited by
- 265
- References
- 188
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.